%0 Journal Article %T Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life %A Petrella, Francesco %A Maisonneuve, Patrick %A Borri, Alessandro %A Casiraghi, Monica %A Donghi, Stefano %A Durkovic, Sava %A Filippi, Niccolo %A Galetta, Domenico %A Gasparri, Roberto %A Guarize, Juliana %A Lo Iacono, Giorgio %A Mariolo, Alessio Vincenzo %A Tessitore, Adele %A Spaggiari, Lorenzo %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life %K %X Background: Malignant pleural effusion (MPE) complicates many neoplasms and its incidence is expected to rise in parallel with the aging population and longer survival of cancer patients. Although a clear consensus exists on indwelling catheters in patients with poor performance status, no study has hitherto compared different devices in patients requiring temporary or definitive drainage following talc poudrage. Methods: This is a prospective, two-arm, pilot study on patients with MPE undergoing talc poudrage, comparing two different catheters (PleurX ® versus Pleurocath ® ) positioned because of the inefficacy of the procedure or the high risk of short-term failure. End points of the study were quality of life (QoL), median dyspnea and chest pain assessment by EORTC questionnaires and a 100 mm visual analog scale, total in-hospital length of stay and frequency of serious adverse events. Results: No difference was observed between the two groups in in mean dyspnea and mean chest pain in any questions of the EORTC QLQ-C30 and QLQ-LC13 questionnaires. Duration of the procedure was significantly longer in the PleurX ® group versus the Pleurocath ® group (72±33 versus 44±13 minutes; P=0.03). No difference was observed between the two groups in total length of hospital stay (P=1.00) or complication rate (P=1.00). Conclusions: For the cohort of patients still needing indwelling pleural catheters (PC) after thoracoscopic talc poudrage, PleurX ® is suggested when drain removal is unlikely due to short life expectancy or the high chance of pleurodesis failure. Conversely, Pleurocath ® should be recommended in all other patients as it is faster to place and easier to remove. %U https://jtd.amegroups.org/article/view/21216 %V 10 %N 5 %P 2999-3004 %@ 2077-6624